1. Maffrand J.P., Eloy F. (1974): Synthèse de thienopyridines et de furopyridines d’interet therapeutique. Eur. J. Med. Chem.,9, 483–486.
2. Aubert D., Pepin O. (1976): Thrombose expérimental: arterielle et veineuse chez le rat wistar. Etude comparative du (chloro-2 benzyl) -5 tétrahydro-4,5,6,7 thieno 3,2c pyridine, chlorhydrate de Ticlopidine et de l’aspirine. In abstracts du 4è Congrès Méditerraneen sur les thromboembolies. Athènes, no 162, p. 99.
3. Matrix C, Blanchard J., Panak E., Thebault J. (1975): Etude chez l’homme d’un nouvel inhibiteur de l’agregation plaquettaire (Ticlopidine). Nouv. Rev. Fr. Hematol.,15, 396.
4. Ferrand J.C., Aubert D., Lacaze B., Pepin C, Thebault J. (1975): In vivo activity of tieclopidine; a new drug with platelet agregation inhibiting, antisludge and antithrombotic properties. Communication at 5th Congress of the International Society on thrombosis and haemostasis. Paris. Abstracts in Amelot ed. no 87,1975, p. 104.
5. Godard Ph., Zini R., Metay A. and Tillement J.P. (1978): The fate of Ticlopidine in the organism: I — Distribution and elimination of Ticlopidine C14 after a single intravenous injection in the Rat. Europ. J. drug Metab. Pharmacokin.,3, 67–71.